Press Releases.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- June 04, 2015-Achieves Key 'Clinical Map Initiative' Goal for 2015 and Advances Orphan Disease Efforts-
- June 01, 2015- Paul Grint, M.D. Appointed as President and Chief Executive Officer and as a Member of the Board of Directors-
- May 07, 2015- Advanced 'Clinical Map Initiative' with Positive Results on RG-101 and Selection of RG-125 as 3rd Clinical Candidate -
- April 25, 2015-RG-101 Achieves Sustained HCV Viral Suppression with Favorable Safety and Tolerability-
- April 09, 2015-Late-breaking data featured in oral presentation; three additional posters examining RG-101 pharmacokinetics, preclinical results to be presented-
- April 07, 2015-Regulus Earns $2.5 Million Milestone Payment from AstraZeneca-
